BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12536477)

  • 1. [Cystic fibrosis: current therapy. Allergic bronchopulmonary aspergillosis (ABPA)].
    Aebischer CC; Schöni MH
    Schweiz Med Wochenschr Suppl; 2000; 122():53S-54S. PubMed ID: 12536477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis].
    van Hoorn JH; Hendriks JJ; Dompeling E; Jöbsis Q
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):594-7. PubMed ID: 15799644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucoviscidosis and allergic bronchopulmonary aspergillosis].
    Paty E; Kramkinel J; de Montalembert M; Lenoir G; Paupe J; de Blic J; Scheinmann P
    Arch Fr Pediatr; 1991 Dec; 48(10):681-4. PubMed ID: 1793341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Thomson JM; Wesley A; Byrnes CA; Nixon GM
    Pediatr Pulmonol; 2006 Feb; 41(2):164-70. PubMed ID: 16317722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
    Salcedo Posadas A
    Enferm Infecc Microbiol Clin; 2000; 18(6):301-3. PubMed ID: 11075497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allergic bronchopulmonary aspergillosis disclosing mucoviscidosis].
    Coltey B; Pin I; Ferretti G; Bonadona A; Pison C; Brambilla C
    Rev Mal Respir; 2001 Oct; 18(5):549-51. PubMed ID: 11887775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.
    Gothe F; Schmautz A; Häusler K; Tran NB; Kappler M; Griese M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2608-2614.e3. PubMed ID: 32147521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
    Wong R; Wong M; Robinson PD; Fitzgerald DA
    Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystic fibrosis and allergic bronchopulmonary aspergillosis (ABPA)].
    Grillot R; Pinel C; Bost M; Lebeau B; Gout JP; Molinier F; Ambroise-Thomas P
    Arch Fr Pediatr; 1992; 49(7):667. PubMed ID: 1476489
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.
    Stevens DA; Moss RB; Kurup VP; Knutsen AP; Greenberger P; Judson MA; Denning DW; Crameri R; Brody AS; Light M; Skov M; Maish W; Mastella G;
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S225-64. PubMed ID: 12975753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
    Zirbes JM; Milla CE
    Pediatr Pulmonol; 2008 Jun; 43(6):607-10. PubMed ID: 18433040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients.
    de Almeida MB; Bussamra MH; Rodrigues JC
    Paediatr Respir Rev; 2006 Mar; 7(1):67-72. PubMed ID: 16473820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
    Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allergic bronchopulmonary aspergillosis and cystic fibrosis. 2 case reports in adults].
    Debieuvre D; Dalphin JC; Leroy J; Estavoyer JM; Bildstein F; Depierre A
    Rev Mal Respir; 1993; 10(4):353-5. PubMed ID: 8235026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.
    Brinkmann F; Schwerk N; Hansen G; Ballmann M
    Allergy; 2010 Jan; 65(1):134-5. PubMed ID: 19804448
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic Bronchopulmonary Aspergillosis.
    Reddy A; Greenberger PA
    J Allergy Clin Immunol Pract; 2017; 5(3):866-867. PubMed ID: 28483324
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serological marker in cystic fibrosis patients.
    Hafen GM; Hartl D; Regamey N; Casaulta C; Latzin P
    Expert Rev Mol Diagn; 2009 Mar; 9(2):157-64. PubMed ID: 19298139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis.
    Epps QJ; Epps KL; Zobell JT; Young DC
    Pediatr Pulmonol; 2020 Dec; 55(12):3541-3572. PubMed ID: 32946194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.
    Cohen-Cymberknoh M; Blau H; Shoseyov D; Mei-Zahav M; Efrati O; Armoni S; Kerem E
    J Cyst Fibros; 2009 Jul; 8(4):253-7. PubMed ID: 19447081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.